Artificial intelligence (AI) software developer Riverain Technologies is unveiling enhancements to its ClearRead AI platform for lung nodule detection at the RSNA 2021 meeting in Chicago.
Workflow enhancements improve the clinical user experience through tighter integration, the firm said. For instance, Fleischner and Lung-RADS scores can be customized to institutional or provider preferences and included in the case-level summary report. Also, lung nodules can be sorted based on diameter, mass, volume, doubling time, and more. Plus, standardized reports have been changed for configurability, language, and readability with a configurable PDF output.
Riverain also upgraded ClearRead's nodule detection so that it shows improved performance on mediastinal nodules, nodule typing, and nodule matching. Finally, the firm has also updated its system service capabilities.
